The at-home molecular testing market size is projected to be worth US$ 10.2 billion in 2023. The market is likely to surpass US$ 18.1 billion by 2033 at a CAGR of 5.9% during the forecast period. Increased infectious illnesses and an increase in the number of diabetes patients around the world are driving the market expansion. For instance, monkey pox and other infectious illnesses pose a severe threat to public health and economic development in all nations. Additionally, the need for early detection of various diseases and growing awareness of them are fueling market expansion.
The prospective growth of the at-home testing market was influenced by the population's growing awareness of home care testing.
Other Drivers Propelling the Demand for At-home Molecular Testing Market include:
Challenges for Companies /Manufacturers in the At-home Molecular Testing Market:
Opportunities in the At-home Molecular Testing Market Industry:
Latest Trends in the At-home Molecular Testing Market:
| Attributes | Details |
|---|---|
| At-home Molecular Testing Market Size (2023) | US$ 10.2 billion |
| At-home Molecular Testing Market Projected Size (2033) | US$ 18.1 billion |
| Value CAGR (2023 to 2033) | 5.9% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global at-home molecular testing market experienced a CAGR of 5.4%, reaching a market size of US$ 10.2 billion in 2023.
From 2017 to 2022, the global at-home molecular testing market industry witnessed steady growth due to the increased awareness and acceptance of at-home molecular testing. The at-home molecular testing market was in its infancy, primarily focused on genetic testing for ancestry and genealogy purposes. Companies like 23andMe and AncestryDNA gained popularity, attracting consumers interested in exploring their genetic heritage. The market witnessed increased awareness and acceptance of at-home molecular testing during this period. More consumers recognized the potential benefits of understanding their genetic health risks and gaining personalized insights. The market diversified to include tests for traits, wellness, and lifestyle factors, such as diet and exercise recommendations based on genetic profiles.
Future Forecast for At-home Molecular Testing Market Industry:
Looking ahead, the global at-home molecular testing market industry is expected to rise at a CAGR of 5.9% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 18.1 billion by 2033.
The at-home molecular testing market industry is expected to continue its growth trajectory from 2023 to 2033. The at-home molecular testing market is expected to witness an expansion of the test menu, offering a wider range of genetic and molecular tests. As scientific knowledge expands, more disease markers, genetic variants, and actionable insights will be identified, leading to the development of new tests. This diversification will attract a larger consumer base and drive market growth.
The growing focus on personalized medicine and preventive healthcare will fuel the demand for at-home molecular testing. Individuals are increasingly interested in understanding their genetic predispositions, optimizing their health choices, and monitoring disease risks. At-home testing provides a convenient and accessible means to achieve these goals.
| Country | The United States |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 5.6 billion |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The at-home molecular testing market industry in the United States is expected to reach a market size of US$ 5.6 billion by 2033, expanding at a CAGR of 7.2%. Due to the rising demand for at home diabetic testing kits. In the United States, more than 130 million persons have diabetes or prediabetes, according to the Centers for Disease Control and Prevention 2022. Such growing prevalence of diabetes in the country, the demand for at home molecular testing market is high.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 689.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The at-home molecular testing market industry in the United Kingdom is expected to reach a market share of US$ 689.1 million, expanding at a CAGR of 6.8% during the forecast period. The United Kingdom market is projected to growth of the market due to the growing personalized medicine initiatives. The United Kingdom has been at the forefront of personalized medicine initiatives, aiming to provide tailored healthcare based on an individual's genetic profile. At-home molecular testing plays a crucial role in these initiatives, allowing individuals to access genetic information, identify disease risks, and participate in research studies to advance personalized healthcare.
| Country | China |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 1.30 billion |
| CAGR % 2023 to End of Forecast (2033) | 5.1% |
The at-home molecular testing market industry in China is anticipated to reach a market size of US$ 1.30 billion, moving at a CAGR of 5.1% during the forecast period. The at-home molecular testing market industry in China is expected to grow prominently due to the increasing chronic disease. China is facing a rising burden of chronic diseases, such as cardiovascular diseases, diabetes, and cancer. At-home molecular testing offers a way for individuals to monitor their health, detect diseases early, and take preventive measures. The ability to access testing from the comfort of their homes aligns with the increasing emphasis on preventive healthcare.
| Country | Japan |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 1.12 billion |
| CAGR % 2023 to End of Forecast (2033) | 5.8% |
The at-home molecular testing market industry in Japan is estimated to reach a market size of US$ 1.12 billion by 2033, thriving at a CAGR of 5.8%. The market in Japan is predicted to grow because of the growing technological advancements. Japan has a well-established e-commerce infrastructure and a high penetration of smartphones. This has facilitated the growth of online platforms and marketplaces for at-home molecular testing kits. The ease of purchasing and accessing these kits online has contributed to the rising demand in the country.
| Country | South Korea |
|---|---|
| Market Size (US$ billion) by End of Forecast Period (2033) | US$ 253.9 million |
| CAGR % 2023 to End of Forecast (2033) | 3.6% |
The at-home molecular testing market industry in South Korea is expected to reach a market size of US$ 253.9 million, expanding at a CAGR of 3.6% during the forecast period. The market in South Korea is forecasted to witness growth due to the increased awareness and acceptance. There has been a growing awareness and acceptance of at-home molecular testing among the general population in the South Korea. Consumers are increasingly interested in understanding their genetic heritage, health risks, and ancestry. This has contributed to the rising demand for at-home genetic testing kits.
Principal Consultant
The cassettes are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 due to its rapid testing procedures, high efficiency, and improved testing kits.
According to the needs of the consumer, diagnostic cassettes for rapid test for diagnostic kits can be used in a single way or many ways (two or four ways). For immediate results, Plastic Cassettes for Rapid Test (Cassettes for Diagnostic Kits) are frequently utilized. For the best outcomes, it also guarantees improved buffer flow with the right pressure points through the strip.
Infectious diseases are expected to dominate the at-home molecular testing market industry with a CAGR of 6.7% from 2023 to 2033. This segment captures a significant market share in 2023 as incidences of infectious diseases in the globe is on the rise.
The prevalence of infectious diseases in developed and developing regions will have a beneficial impact on market growth. The increasing number of prescriptions for at-home infectious illness diagnostic tests is due to the diagnosis and management of such infections.
The blood sample segment is expected to dominate the at-home molecular testing market industry with a CAGR of 5.5% from 2023 to 2033 and is expected to hold market share of 42.4% in 2023. Blood testing are extremely common. They aid clinicians in the detection of certain diseases and ailments. They also aid in the evaluation of organ function and the effectiveness of treatments. One of the most popular blood tests is the complete blood count (CBC). It is frequently performed as part of a standard checkup. This test evaluates a variety of blood components, including red blood cells, white blood cells, and platelets.
The drug store in dominating the at home molecular testing market with the CAGR of 6.2%. The ease of availability of the testing kits without prescription in the drug store the adoption is high.
The at-home molecular testing sector is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic alliances and partnerships with other businesses are regularly formed by major players in an industry to take advantage of each other's advantages and expand their market reach. Through such arrangements, businesses may also obtain access to new technologies and markets.
The market for at-home molecular testing is rising quickly in developing nations like China and India. To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites.
Key companies in the at-home molecular testing market routinely employ mergers and acquisitions to strengthen their market positions, broaden their product offerings, and enter new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the At-home Molecular Testing Market:
The at-home molecular testing market CAGR for 2033 is 5.9%.
The North America region is the leading region in the market.
The projected market value of the market for 2033 is US$ 10.2 billion.
Key players are developing the market by developing innovative tests.
China, India, the United States, Japan, and Germany are the major countries in this market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product Features/ USPs 4.3. Technological Roadmap 4.4. Recent Product Approvals/Launces 4.5. Reimbursement Scenario 4.6. Regulatory Landscape 4.7. PESTEL Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Increasing Cases of Infectious Diseases 5.2.3. Favourable Government Regulations 5.2.4. Rising Demand for At Home Kits 5.2.5. Technological Advancement in the Devices 5.2.6. Increasing Prevalence of Diabetes 5.2.7. Growing Product Demand For Genetic Predispositions 5.2.8. Increasing Product Approvals/Launches 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2017 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 9.3.1. Cassettes 9.3.2. Strips 9.3.3. Test Panels 9.3.4. Dip Cards 9.3.5. Midstreams 9.3.6. Others 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Test Type, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033 10.3.1. Pregnancy Tests 10.3.2. HIV Tests 10.3.3. Diabetes 10.3.4. Infectious Diseases 10.3.5. Glucose Tests 10.3.6. Ovulation Predictor Tests 10.3.7. Drug Abuse Tests 10.3.8. Others 10.4. Market Attractiveness Analysis By Test Type 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample Type 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Sample Type, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033 11.3.1. Urine 11.3.2. Blood 11.3.3. Saliva 11.3.4. Others 11.4. Market Attractiveness Analysis By Sample Type 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By Distribution Channel, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033 12.3.1. Retail Pharmacies 12.3.2. Drug Stores 12.3.3. Supermarkets/Hypermarkets 12.3.4. Online Pharmacies 12.4. Market Attractiveness Analysis By Distribution Channel 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Test Type 14.3.4. By Sample Type 14.3.5. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Test Type 14.4.4. By Sample Type 14.4.5. By Distribution Channel 14.5. Country Level Analysis & Forecast 14.5.1. USA Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Test Type 14.5.1.2.3. By Sample Type 14.5.1.2.4. By Distribution Channel 14.5.2. Canada Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Test Type 14.5.2.2.3. By Sample Type 14.5.2.2.4. By Distribution Channel 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Test Type 15.3.4. By Sample Type 15.3.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Test Type 15.4.4. By Sample Type 15.4.5. By Distribution Channel 15.5. Country Level Analysis & Forecast 15.5.1. Brazil Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Test Type 15.5.1.2.3. By Sample Type 15.5.1.2.4. By Distribution Channel 15.5.2. Mexico Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Test Type 15.5.2.2.3. By Sample Type 15.5.2.2.4. By Distribution Channel 15.5.3. Argentina Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Test Type 15.5.3.2.3. By Sample Type 15.5.3.2.4. By Distribution Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. France 16.3.1.3. Italy 16.3.1.4. UK 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Rest of Europe 16.3.2. By Product 16.3.3. By Test Type 16.3.4. By Sample Type 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Test Type 16.4.4. By Sample Type 16.4.5. By Distribution Channel 16.5. Country Level Analysis & Forecast 16.5.1. Germany Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Test Type 16.5.1.2.3. By Sample Type 16.5.1.2.4. By Distribution Channel 16.5.2. France Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Test Type 16.5.2.2.3. By Sample Type 16.5.2.2.4. By Distribution Channel 16.5.3. Italy Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Test Type 16.5.3.2.3. By Sample Type 16.5.3.2.4. By Distribution Channel 16.5.4. UK Market Analysis 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Test Type 16.5.4.2.3. By Sample Type 16.5.4.2.4. By Distribution Channel 16.5.5. Spain Market Analysis 16.5.5.1. Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Product 16.5.5.2.2. By Test Type 16.5.5.2.3. By Sample Type 16.5.5.2.4. By Distribution Channel 16.5.6. Russia Market Analysis 16.5.6.1. Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Product 16.5.6.2.2. By Test Type 16.5.6.2.3. By Sample Type 16.5.6.2.4. By Distribution Channel 16.5.7. BENELUX Market Analysis 16.5.7.1. Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Product 16.5.7.2.2. By Test Type 16.5.7.2.3. By Sample Type 16.5.7.2.4. By Distribution Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Test Type 17.3.4. By Sample Type 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Test Type 17.4.4. By Sample Type 17.4.5. By Distribution Channel 17.5. Country Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Test Type 17.5.1.2.3. By Sample Type 17.5.1.2.4. By Distribution Channel 17.5.2. Thailand Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Test Type 17.5.2.2.3. By Sample Type 17.5.2.2.4. By Distribution Channel 17.5.3. Indonesia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Test Type 17.5.3.2.3. By Sample Type 17.5.3.2.4. By Distribution Channel 17.5.4. Malaysia Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product 17.5.4.2.2. By Test Type 17.5.4.2.3. By Sample Type 17.5.4.2.4. By Distribution Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Test Type 18.3.4. By Sample Type 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Test Type 18.4.4. By Sample Type 18.4.5. By Distribution Channel 18.5. Country Level Analysis & Forecast 18.5.1. China Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Test Type 18.5.1.2.3. By Sample Type 18.5.1.2.4. By Distribution Channel 18.5.2. Japan Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Test Type 18.5.2.2.3. By Sample Type 18.5.2.2.4. By Distribution Channel 18.5.3. South Korea Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Test Type 18.5.3.2.3. By Sample Type 18.5.3.2.4. By Distribution Channel 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Test Type 19.3.4. By Sample Type 19.3.5. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Test Type 19.4.4. By Sample Type 19.4.5. By Distribution Channel 19.5. Country Level Analysis & Forecast 19.5.1. Australia Market Analysis 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Test Type 19.5.1.2.3. By Sample Type 19.5.1.2.4. By Distribution Channel 19.5.2. New Zealand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Test Type 19.5.2.2.3. By Sample Type 19.5.2.2.4. By Distribution Channel 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Test Type 20.3.4. By Sample Type 20.3.5. By Distribution Channel 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Test Type 20.4.4. By Sample Type 20.4.5. By Distribution Channel 20.5. Country Level Analysis & Forecast 20.5.1. GCC Countries Market Analysis 20.5.1.1. Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product 20.5.1.2.2. By Test Type 20.5.1.2.3. By Sample Type 20.5.1.2.4. By Distribution Channel 20.5.2. Türkiye Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product 20.5.2.2.2. By Test Type 20.5.2.2.3. By Sample Type 20.5.2.2.4. By Distribution Channel 20.5.3. Northern Africa Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product 20.5.3.2.2. By Test Type 20.5.3.2.3. By Sample Type 20.5.3.2.4. By Distribution Channel 20.5.4. South Africa Market Analysis 20.5.4.1. Introduction 20.5.4.2. Market Analysis and Forecast by Market Taxonomy 20.5.4.2.1. By Product 20.5.4.2.2. By Test Type 20.5.4.2.3. By Sample Type 20.5.4.2.4. By Distribution Channel 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Branding and Promotional Strategies, By Key Players 22.3. Key Development Analysis 22.4. Competition Deep Dive 22.4.1. Abbott 22.4.1.1. Overview 22.4.1.2. Product Portfolio 22.4.1.3. Key Financials 22.4.1.4. Sales Footprint 22.4.1.5. SWOT Analysis 22.4.1.6. Strategy Overview 22.4.1.6.1. Marketing Strategy 22.4.1.6.2. Product Strategy 22.4.1.6.3. Channel Strategy 22.4.2. Rapikit 22.4.2.1. Overview 22.4.2.2. Product Portfolio 22.4.2.3. Key Financials 22.4.2.4. Sales Footprint 22.4.2.5. SWOT Analysis 22.4.2.6. Strategy Overview 22.4.2.6.1. Marketing Strategy 22.4.2.6.2. Product Strategy 22.4.2.6.3. Channel Strategy 22.4.3. Becton and Dickinson 22.4.3.1. Overview 22.4.3.2. Product Portfolio 22.4.3.3. Key Financials 22.4.3.4. Sales Footprint 22.4.3.5. SWOT Analysis 22.4.3.6. Strategy Overview 22.4.3.6.1. Marketing Strategy 22.4.3.6.2. Product Strategy 22.4.3.6.3. Channel Strategy 22.4.4. Cardinal Health 22.4.4.1. Overview 22.4.4.2. Product Portfolio 22.4.4.3. Key Financials 22.4.4.4. Sales Footprint 22.4.4.5. SWOT Analysis 22.4.4.6. Strategy Overview 22.4.4.6.1. Marketing Strategy 22.4.4.6.2. Product Strategy 22.4.4.6.3. Channel Strategy 22.4.5. B. Braun Melsungen AG 22.4.5.1. Overview 22.4.5.2. Product Portfolio 22.4.5.3. Key Financials 22.4.5.4. Sales Footprint 22.4.5.5. SWOT Analysis 22.4.5.6. Strategy Overview 22.4.5.6.1. Marketing Strategy 22.4.5.6.2. Product Strategy 22.4.5.6.3. Channel Strategy 22.4.6. Piramal Enterprises Ltd. 22.4.6.1. Overview 22.4.6.2. Product Portfolio 22.4.6.3. Key Financials 22.4.6.4. Sales Footprint 22.4.6.5. SWOT Analysis 22.4.6.6. Strategy Overview 22.4.6.6.1. Marketing Strategy 22.4.6.6.2. Product Strategy 22.4.6.6.3. Channel Strategy 22.4.7. Siemens Healthcare GmbH 22.4.7.1. Overview 22.4.7.2. Product Portfolio 22.4.7.3. Key Financials 22.4.7.4. Sales Footprint 22.4.7.5. SWOT Analysis 22.4.7.6. Strategy Overview 22.4.7.6.1. Marketing Strategy 22.4.7.6.2. Product Strategy 22.4.7.6.3. Channel Strategy 22.4.8. Quidel Corporation 22.4.8.1. Overview 22.4.8.2. Product Portfolio 22.4.8.3. Key Financials 22.4.8.4. Sales Footprint 22.4.8.5. SWOT Analysis 22.4.8.6. Strategy Overview 22.4.8.6.1. Marketing Strategy 22.4.8.6.2. Product Strategy 22.4.8.6.3. Channel Strategy 22.4.9. Bionime Corporation 22.4.9.1. Overview 22.4.9.2. Product Portfolio 22.4.9.3. Key Financials 22.4.9.4. Sales Footprint 22.4.9.5. SWOT Analysis 22.4.9.6. Strategy Overview 22.4.9.6.1. Marketing Strategy 22.4.9.6.2. Product Strategy 22.4.9.6.3. Channel Strategy 22.4.10. SA Scientific 22.4.10.1. Overview 22.4.10.2. Product Portfolio 22.4.10.3. Key Financials 22.4.10.4. Sales Footprint 22.4.10.5. SWOT Analysis 22.4.10.6. Strategy Overview 22.4.10.6.1. Marketing Strategy 22.4.10.6.2. Product Strategy 22.4.10.6.3. Channel Strategy 22.4.11. ARKRAY USA, Inc. 22.4.11.1. Overview 22.4.11.2. Product Portfolio 22.4.11.3. Key Financials 22.4.11.4. Sales Footprint 22.4.11.5. SWOT Analysis 22.4.11.6. Strategy Overview 22.4.11.6.1. Marketing Strategy 22.4.11.6.2. Product Strategy 22.4.11.6.3. Channel Strategy 22.4.12. Nova Biomedical 22.4.12.1. Overview 22.4.12.2. Product Portfolio 22.4.12.3. Key Financials 22.4.12.4. Sales Footprint 22.4.12.5. SWOT Analysis 22.4.12.6. Strategy Overview 22.4.12.6.1. Marketing Strategy 22.4.12.6.2. Product Strategy 22.4.12.6.3. Channel Strategy 22.4.13. AdvaCare Pharma 22.4.13.1. Overview 22.4.13.2. Product Portfolio 22.4.13.3. Key Financials 22.4.13.4. Sales Footprint 22.4.13.5. SWOT Analysis 22.4.13.6. Strategy Overview 22.4.13.6.1. Marketing Strategy 22.4.13.6.2. Product Strategy 22.4.13.6.3. Channel Strategy 22.4.14. AccuBioTech Co., Ltd. 22.4.14.1. Overview 22.4.14.2. Product Portfolio 22.4.14.3. Key Financials 22.4.14.4. Sales Footprint 22.4.14.5. SWOT Analysis 22.4.14.6. Strategy Overview 22.4.14.6.1. Marketing Strategy 22.4.14.6.2. Product Strategy 22.4.14.6.3. Channel Strategy 22.4.15. Atlas Medical UK 22.4.15.1. Overview 22.4.15.2. Product Portfolio 22.4.15.3. Key Financials 22.4.15.4. Sales Footprint 22.4.15.5. SWOT Analysis 22.4.15.6. Strategy Overview 22.4.15.6.1. Marketing Strategy 22.4.15.6.2. Product Strategy 22.4.15.6.3. Channel Strategy 22.4.16. TaiDoc Technology Corporation 22.4.16.1. Overview 22.4.16.2. Product Portfolio 22.4.16.3. Key Financials 22.4.16.4. Sales Footprint 22.4.16.5. SWOT Analysis 22.4.16.6. Strategy Overview 22.4.16.6.1. Marketing Strategy 22.4.16.6.2. Product Strategy 22.4.16.6.3. Channel Strategy 22.4.17. Drägerwerk AG & Co. KGaA 22.4.17.1. Overview 22.4.17.2. Product Portfolio 22.4.17.3. Key Financials 22.4.17.4. Sales Footprint 22.4.17.5. SWOT Analysis 22.4.17.6. Strategy Overview 22.4.17.6.1. Marketing Strategy 22.4.17.6.2. Product Strategy 22.4.17.6.3. Channel Strategy 22.4.18. F. Hoffmann-La Roche Ltd 22.4.18.1. Overview 22.4.18.2. Product Portfolio 22.4.18.3. Key Financials 22.4.18.4. Sales Footprint 22.4.18.5. SWOT Analysis 22.4.18.6. Strategy Overview 22.4.18.6.1. Marketing Strategy 22.4.18.6.2. Product Strategy 22.4.18.6.3. Channel Strategy 22.4.19. Sensing Self 22.4.19.1. Overview 22.4.19.2. Product Portfolio 22.4.19.3. Key Financials 22.4.19.4. Sales Footprint 22.4.19.5. SWOT Analysis 22.4.19.6. Strategy Overview 22.4.19.6.1. Marketing Strategy 22.4.19.6.2. Product Strategy 22.4.19.6.3. Channel Strategy 22.4.20. PTE. Ltd 22.4.20.1. Overview 22.4.20.2. Product Portfolio 22.4.20.3. Key Financials 22.4.20.4. Sales Footprint 22.4.20.5. SWOT Analysis 22.4.20.6. Strategy Overview 22.4.20.6.1. Marketing Strategy 22.4.20.6.2. Product Strategy 22.4.20.6.3. Channel Strategy 22.4.21. Atomo Diagnostics 22.4.21.1. Overview 22.4.21.2. Product Portfolio 22.4.21.3. Key Financials 22.4.21.4. Sales Footprint 22.4.21.5. SWOT Analysis 22.4.21.6. Strategy Overview 22.4.21.6.1. Marketing Strategy 22.4.21.6.2. Product Strategy 22.4.21.6.3. Channel Strategy 22.4.22. Mankind Pharma 22.4.22.1. Overview 22.4.22.2. Product Portfolio 22.4.22.3. Key Financials 22.4.22.4. Sales Footprint 22.4.22.5. SWOT Analysis 22.4.22.6. Strategy Overview 22.4.22.6.1. Marketing Strategy 22.4.22.6.2. Product Strategy 22.4.22.6.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
At-home Molecular Testing Market
